Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Author(s) -
Falcão,
Carneiro,
Mendonça,
Sofia Fonseca,
Brandão,
Fernando FalcãoReis
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s33017
Subject(s) - ranibizumab , medicine , bevacizumab , ophthalmology , macular degeneration , visual acuity , regimen , surgery , chemotherapy
We compared the efficacy of intravitreal ranibizumab and bevacizumab for treating neovascular age-related macular degeneration using an on-demand regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom